Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Zuranolone for treating moderate to severe postpartum depression Zuranolone Postpartum depression Mental and Behavioural Health 2023 View  |  Download
Zanubrutinib plus obinutuzumab for treating relapsed or refractory follicular lymphoma Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) , Zanubrutinib (BGB-3111; Brukinsa) Follicular lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Zanubrutinib for previously treated mantle cell lymphoma Zanubrutinib (BGB-3111; Brukinsa) Mantle cell lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Zanidatamab for treating advanced or metastatic HER2-positive biliary tract cancer in adults Zanidatamab (ZW-25) Biliary tract cancer Gastrointestinal Cancer 2023 View  |  Download
Xeomin (Botulinum neurotoxin type A) for lower limb and/or upper limb spasticity Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Lower limb spasticity , Upper limb spasticity Musculoskeletal System 2023 View  |  Download
WP1048 for treating grass pollen allergy WP1048 Grass pollen allergy Ear Nose and Throat (ENT) , Immunology 2023 View  |  Download
Vorasidenib for treating residual or recurrent grade 2 glioma Vorasidenib Glioma Neurological Cancer 2023 View  |  Download
Vonicog alfa for Prophylaxis of Haemorrhage in Von Willebrand disease Vonicog alfa (recombinant von Willebrand factor) von Willebrand disease Genetic Disorders , Haematology 2023 View  |  Download
Vibostolimab-pembrolizumab for previously untreated PD-L1-positive metastatic non-small cell lung cancer Pembrolizumab-vibostolimab (MK-7684; MK7684A; Vibostolimab) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Vibegron for treating overactive bladder Vibegron (MK-418; Gemtesa; Beova) Overactive bladder Urology 2023 View  |  Download
1 2 3 18 19
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications